Phillip Dennis

Company: Sanofi

Job title: Vice President, Lung Cancer & Oncology Development

Seminars:

Advancements in ADCs for later-line NSCLC 3:00 pm

Exploring the latest translational research Discussing potential combinations and treatment line Latest data and future directionsRead more

day: Day One

Panel Discussion: Exploring the Strategic Challenges of Moving Forward a Drug You Want to Combine with PD-1 in Chemo+PD-1 Progressors 12:30 pm

Understanding the different current comparators and benchmarks Exploring the differences in PD-1 naïve and PD-1 progressors Dissecting why sometimes beating chemo and PD-1 could be an unachievable bar Discussing whether with late-line in-effectivity, how you know it won’t work in early line? Considering the health authorities’ standards on the matterRead more

day: Day One